We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Show more
Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.02 | 1.35135135135 | 1.48 | 1.7382 | 1.4 | 317413 | 1.55274564 | CS |
4 | 0.03 | 2.04081632653 | 1.47 | 1.7382 | 1.22 | 461028 | 1.42731104 | CS |
12 | -3.66 | -70.9302325581 | 5.16 | 5.82 | 1.0404 | 1026225 | 2.12458896 | CS |
26 | -5.54 | -78.6931818182 | 7.04 | 11.41 | 1.0404 | 602008 | 3.31112089 | CS |
52 | -2.21 | -59.5687331536 | 3.71 | 11.41 | 1.0404 | 620118 | 4.65491645 | CS |
156 | -11.16 | -88.1516587678 | 12.66 | 13.535 | 1.0404 | 348779 | 4.66285731 | CS |
260 | -12.15 | -89.010989011 | 13.65 | 18.67 | 1.0404 | 249793 | 5.75345758 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions